Akero Therapeutics, Inc.
South San Francisco, US · Founded 2017 · 2 known investors
Find your way into Akero Therapeutics, Inc.
Sign up to see every warm intro you have to Akero Therapeutics, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Akero Therapeutics, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Akero Therapeutics, Inc. was founded in 2017 by Andrew Cheng.
AC
Andrew ChengFounder
Board
Investors · 2
Reported raises · per SEC filings
Form D private placements$45.5M disclosed across 1 round · 2018
▶$45.5MraisedDec 2018 · 20 investors · Other Health CareRule 506(b)
▶$45.5MraisedDec 2018 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Aaron KantoffDirector
- Aaron RoystonDirector
- Mark IwickiDirector
- Graham WalmsleyDirector
- Jonathan YoungExecutive Officer
- Kevin BittermanDirector
- Andrew ChengExecutive Officer, Director
- Offering amount
- $45.5M
- Amount sold
- $45.5M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Akero Therapeutics, Inc.?
- Akero Therapeutics, Inc. was founded by Andrew Cheng in 2017.
- Who are Akero Therapeutics, Inc.'s investors?
- Akero Therapeutics, Inc.'s investors include Atlas Venture, venBio Partners.
- How much funding has Akero Therapeutics, Inc. raised?
- Akero Therapeutics, Inc. has disclosed $45.5M raised across 1 round.
- Where is Akero Therapeutics, Inc. headquartered?
- Akero Therapeutics, Inc. is headquartered in South San Francisco, US.


